BCBP

Summary

Sell BCBP (BCB Bancorp, Inc.) into strength near the entry zone; exit or materially lighten all longs and initiate no new longs. Keep any residual tactical position very small given 3% daily ATR, 108% implied volatility and unquantified Q3 event risk. Our analysis sees invalidation on a daily close above near-term resistance on expanding volume, then above medium-term moving averages; breakdown confirmation below short-term support. Time horizon: 5 trading days; remain sidelined until loan-sale size/discount, quantified Q3 loss, and pro forma capital/tangible book for BCBP are disclosed.

The case

Sell BCBP for BCB Bancorp, Inc. because verified dilution plus warned-but-unmeasured credit loss plus intact medium downtrend outweigh short-term repair. BCBP fell 27.9% from the early June high to the mid-September low, then snapped above short-term trend and averages, with RSI repaired and MACD improving but still negative. That is repair not reversal: BCBP remains more than 5% below its falling medium-term average and below its long-term average, stalled at the upper band on fading volume. The anchor is dilution math per our analysis: new shares in the $98 offering versus prior shares outstanding (about 70% increase, with over-allotment closed), making the lower offering level gravity and every rally into the supply zone potential supply. Fundamentals confirm overhang: problem-loan sale with no price, substantial Q3 loss warning with no quantification and no pro forma book, revenue at a multi-quarter low, stale book multiple as retained earnings and equity already fell and the Q3 loss and tangible-book adjustment are not yet booked, cash down about $97 to pay debt, fair value cut with street targets forming a ceiling. Bull points for BCBP — multiple closes holding above short trend, no death cross, room to higher RSI, debt down 54% with falling interest expense, core net interest up quarter over quarter, multiple straight quarters of positive operating cash, chief executive buying shares for $1.24, dividend suspension saving $1.9 per quarter — do not justify buying before the hole is measured and the bounce already stalled at resistance. With no prior resolved history for name calibration, our analysis warns against chasing this upper-band test and requires a daily close above resistance on expansion then reclaim of medium- and long-term averages before reconsidering, while an outright exit here is justified because this is not a coiled neutral — it is a defined-supply capped bounce with locked-in dilution and event risk, justifying using strength near the entry zone to exit and lighten BCBP.

What would weaken it

• Unquantified Q3 loss and loan-sale terms could deepen downside
• Bounce holds and reclaims medium averages, invalidating Sell
• Heavy diluted supply caps every rally into strength